the gonadotropin-releasing activity of synthetic alpha msh , previously found in normal men , was evaluated in women with different hormonal environments and in patients with acyclic gonadotropin release due to hypothalamic-pituitary dysfunction . alpha msh ( 2.5 mg , iv ) administered as either a single or two repeated pulses ( at 2-h intervals ) elicited unequivocal pituitary release of lh in normal women during the luteal phase and midcycle surge and in patients with functional hypothalamic amenorrhea , hyperprolactinemic amenorrhea , and polycystic ovary syndrome .
C0018061
gonadotropin
C0018066
gonadotropin